CELSR3 and head and neck squamous cell carcinoma: Furthermore, cytokine and immune checkpoint blockade therapy have become treatment options for a variety of cancers, but no research has been conducted to determine whether CELSR3 overexpression influences the tumor immune microenvironment in HNSCC.